精准肿瘤学市场- 按产品类型（诊断{基因测试、基于生物标记的测试}、治疗）、癌症类型（乳腺癌、肺癌、结直肠癌、皮肤、前列腺、胃）、最终用户（医院、诊断中心）、全球预测2023-2032

在基因组研究不断进步的推动下，精准肿瘤学市场预计从 2023 年到 2032 年将以 10.6% 的复合CAGR扩张。最近在了解癌症遗传基础方面的突破使得能够精确识别分子变化并推动标靶治疗的发展。下一代定序等技术的不断发展也提供了全面的基因组分析。一些肿瘤学家正在根据个别患者的情况量身定制这些疗法，以提供个人化和有针对性的癌症护理。

此外，一些公司正在透过业务发展的合作和收购等策略性努力，将优质的后期精准肿瘤学资产添加到其业务概况中，从而扩大其肿瘤学服务，从而增强行业前景。例如，2022 年 3 月，百时美施贵宝收购了领先的精准肿瘤公司 Turning Point Therapeutics。

整个产业分为产品类型、癌症类型、最终用户和地区。

根据产品类型，诊断领域的精准肿瘤市场预计 2023 年至 2032 年CAGR为 11.7%。先进的诊断工具和技术，包括下一代定序、分子影像和液体活检分析，正在促进精准肿瘤学的日益普及。诊断产品不断发展以提供更高的准确性和效率，从而增强了其在肿瘤学领域的应用。此外，对全面基因组分析、肿瘤特征和早期癌症检测以支持个人化治疗策略的需求激增，将推动该细分市场的成长。

对于最终用户而言，到 2032 年，诊断中心的精准肿瘤学产业预计将以 11.4% 的成长率成长。癌症发生率的增加导致对精准和个人化诊断解决方案的需求不断增长。诊断中心在提供先进的分子分析和基因检测服务以实现标靶癌症治疗方面也发挥关键作用。人们越来越认识到使用精准医学进行更有效的癌症治疗所带来的好处，这将进一步扩大肿瘤学诊断服务的使用。

从地区来看，由于癌症发生率的增加、意识的提高以及基因组研究的快速进步，亚太地区精准肿瘤学市场预计在 2023 年至 2032 年间呈现 11.4% 的成长率。例如，根据 NCBI 估计，印度报告 2022 年癌症发生率为 14,61,427 例。此外，亚太地区的多个政府和医疗机构正在投资精准肿瘤学计划，进一步促进个人化癌症治疗方法。此外，该地区多样化的患者群体为鼓励采用精准医疗、加速区域产业扩张提供了宝贵的遗传见解。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：精准肿瘤学市场洞察

• 产业格局
• 产业影响力
  • 成长动力
    • 癌症盛行率增加
    • 技术进步
    • 对个人化医疗的需求不断增长
    • 政府措施和资金不断增加
  • 产业陷阱与挑战
    • 精准医疗成本高
    • 严格的监管要求
• 成长潜力分析
• COVID-19 影响分析
• 监管环境
  • 我们
  • 欧洲
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：精准肿瘤学市场估计与预测：按产品类型，2018-2032 年

• 主要动向：依产品类型
• 疗法
• 诊断
  • 基于生物标誌物的测试
  • 基因测试
  • 其他诊断

第 6 章：精准肿瘤学市场估计与预测：按癌症类型，2018-2032 年

• 主要动力向：按癌症类型
• 乳癌
• 肺癌
• 大肠直肠癌
• 摄护腺癌
• 皮肤癌
• 胃癌
• 其他癌症类型

第 7 章：精准肿瘤学市场估计与预测：按最终用户，2018-2032 年

• 主要动向：按应用
• 诊断中心
• 医院
• 研究与学术机构
• 其他最终用户

第 8 章：精准肿瘤学市场估计与预测：按地区，2018 - 2032

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 9 章：公司简介

• Thermo Fisher Scientific Inc.
• Invitae Corporation
• Illumina, Inc.
• Qiagen N.V.
• Novartis AG
• Erasca Inc
• F. Hoffmann-La Roche AG
• Rain Therapeutics Inc
• Agendia Inc
• Strata Oncology, Inc

Precision Oncology Market is set to expand at 10.6% CAGR from 2023 and 2032 propelled by the continuous advancements in genomic research. Recent breakthroughs in understanding the genetic basis of cancers is enabling the precise identification of molecular alterations and driving the development of targeted therapies. The ongoing evolution of technologies like next-generation sequencing is also providing comprehensive genomic profiling. Several oncologists are tailoring these therapies based on individual patient profiles to provide personalized and targeted cancer care.

Furthermore, several companies are expanding their oncology services by adding superior, late-stage precision oncology assets to their business profiles through strategic efforts, such as collaborations and acquisitions for business development, augmenting the industry outlook. For instance, in March 2022, Bristol Myers Squibb acquired Turning Point Therapeutics, a leading precision oncology company.

The overall industry is segmented into product type, cancer type, end-user, and region.

Based on product type, the precision oncology market from the diagnostic segment is projected to grow at 11.7% CAGR from 2023-2032. Advanced diagnostic tools and technologies, including next-generation sequencing, molecular imaging, and liquid biopsy assays, are contributing to the increasing adoption of precision oncology. The continuous evolution of diagnostic products for offering higher accuracy and efficiency is enhancing their adoption in oncology settings. Additionally, the surging need to enable comprehensive genomic profiling, tumor characterization, and early cancer detection for supporting personalized treatment strategies will drive the segment growth.

As per end-user, the precision oncology industry from the diagnostic centers is expected to depict 11.4% growth rate through 2032. The increasing number of cancer incidences is resulting in the rising demand for precise and personalized diagnostic solutions. Diagnostic centers also play a pivotal role in offering advanced molecular profiling and genetic testing services for enabling targeted cancer therapies. The rising awareness of the benefits associated with the use of precision medicine for more effective cancer treatments will further amplify the use of diagnostic services in oncology.

Regionally, the Asia Pacific precision oncology market is set to exhibit an 11.4% growth rate between 2023 and 2032 attributed to the increasing cancer incidences, rising awareness, and the rapid advancements in genomic research. For instance, according to NCBI estimates, India reported 14,61,427 incidence cases of cancer in 2022. Moreover, several governments and healthcare institutions in APAC are investing in precision oncology initiatives, further fostering personalized cancer treatment approaches. Additionally, the diverse patient populations in the region is offering valuable genetic insights for encouraging the adoption of precision medicine, accelerating the regional industry expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Precision oncology industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Product type trends
  • 2.1.4 Cancer type trends
  • 2.1.5 End-user trends

Chapter 3 Precision Oncology Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of cancer
    • 3.2.1.2 Advancement in technologies
    • 3.2.1.3 Increasing demand for personalized medicine
    • 3.2.1.4 Rising government initiatives and funding
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of precision medicine
    • 3.2.2.2 Stringent regulatory requirements
• 3.3 Growth potential analysis
  • 3.3.1 By product type
  • 3.3.2 By cancer type
  • 3.3.3 By end-user
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
  • 3.5.1 U.S.
  • 3.5.2 Europe
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Precision Oncology Market Estimates and Forecast, By Product Type, 2018-2032 (USD Million)

• 5.1 Key trends, by product type
• 5.2 Therapeutics
• 5.3 Diagnostics
  • 5.3.1 Biomarker based tests
  • 5.3.2 Genetic tests
  • 5.3.3 Other diagnostics

Chapter 6 Precision Oncology Market Estimates and Forecast, By Cancer Type, 2018-2032 (USD Million)

• 6.1 Key trends, by cancer type
• 6.2 Breast cancer
• 6.3 Lung cancer
• 6.4 Colorectal cancer
• 6.5 Prostate cancer
• 6.6 Skin cancer
• 6.7 Stomach cancer
• 6.8 Other cancer types

Chapter 7 Precision Oncology Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)

• 7.1 Key trends, by application
• 7.2 Diagnostic centers
• 7.3 Hospitals
• 7.4 Research & academic institutes
• 7.5 Other end-users

Chapter 8 Precision Oncology Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Thermo Fisher Scientific Inc.
• 9.2 Invitae Corporation
• 9.3 Illumina, Inc.
• 9.4 Qiagen N.V.
• 9.5 Novartis AG
• 9.6 Erasca Inc
• 9.7 F. Hoffmann-La Roche AG
• 9.8 Rain Therapeutics Inc
• 9.9 Agendia Inc
• 9.10 Strata Oncology, Inc

Data Tables

• TABLE 1 Market revenue, by product type (2022)
• TABLE 2 Market revenue, by cancer type (2022)
• TABLE 3 Market revenue, by end-user (2022)
• TABLE 4 Market share, by region (2022)
• TABLE 5 Global precision oncology market size, by region, 2018 - 2022 (USD Million)
• TABLE 6 Global precision oncology market size, by region, 2023 - 2032 (USD Million)
• TABLE 7 Global precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 8 Global precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 9 Global precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 10 Global precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 11 Global precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 12 Global precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 13 Industry impact forces
• TABLE 14 Therapeutics market, 2018 - 2022 (USD Million)
• TABLE 15 Therapeutics market, 2023 - 2032 (USD Million)
• TABLE 16 Diagnostics market, 2018 - 2022 (USD Million)
• TABLE 17 Diagnostics market, 2023 - 2032 (USD Million)
• TABLE 18 Biomarker based tests market, 2018 - 2022 (USD Million)
• TABLE 19 Biomarker based tests market, 2023 - 2032 (USD Million)
• TABLE 20 Genetic tests market, 2018 - 2022 (USD Million)
• TABLE 21 Genetic tests market, 2023 - 2032 (USD Million)
• TABLE 22 Other diagnostics market, 2018 - 2022 (USD Million)
• TABLE 23 Other diagnostics market, 2023 - 2032 (USD Million)
• TABLE 24 Breast cancer market, 2018 - 2022 (USD Million)
• TABLE 25 Breast cancer market, 2023 - 2032 (USD Million)
• TABLE 26 Lung cancer market, 2018 - 2022 (USD Million)
• TABLE 27 Lung cancer market, 2023 - 2032 (USD Million)
• TABLE 28 Colorectal cancer market, 2018 - 2022 (USD Million)
• TABLE 29 Colorectal cancer market, 2023 - 2032 (USD Million)
• TABLE 30 Prostrate market, 2018 - 2022 (USD Million)
• TABLE 31 Prostrate market, 2023 - 2032 (USD Million)
• TABLE 32 Skin cancer market, 2018 - 2022 (USD Million)
• TABLE 33 Skin cancer market, 2023 - 2032 (USD Million)
• TABLE 34 Stomach cancer market, 2018 - 2022 (USD Million)
• TABLE 35 Stomach cancer market, 2023 - 2032 (USD Million)
• TABLE 36 Other cancer types market, 2018 - 2022 (USD Million)
• TABLE 37 Other cancer types market, 2023 - 2032 (USD Million)
• TABLE 38 Hospitals market, 2018 - 2022 (USD Million)
• TABLE 39 Hospitals market, 2023 - 2032 (USD Million)
• TABLE 40 Diagnostic centers market, 2018 - 2022 (USD Million)
• TABLE 41 Diagnostic centers market, 2023 - 2032 (USD Million)
• TABLE 42 Research & academic institutes market, 2018 - 2022 (USD Million)
• TABLE 43 Research & academic institutes market, 2023 - 2032 (USD Million)
• TABLE 44 Other end-users market, 2018 - 2022 (USD Million)
• TABLE 45 Other end-users market, 2023 - 2032 (USD Million)
• TABLE 46 North America precision oncology market size, by country, 2018 - 2022 (USD Million)
• TABLE 47 North America precision oncology market size, by country, 2023 - 2032 (USD Million)
• TABLE 48 North America precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 49 North America precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 50 North America precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 51 North America precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 52 North America precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 53 North America precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 54 North America precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 55 North America precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 56 U.S. precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 57 U.S. precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 58 U.S. precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 59 U.S. precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 60 U.S. precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 61 U.S. precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 62 U.S. precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 63 U.S. precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 64 Canada precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 65 Canada precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 66 Canada precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 67 Canada precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 68 Canada precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 69 Canada precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 70 Canada precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 71 Canada precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 72 Europe precision oncology market size, by country, 2018 - 2022 (USD Million)
• TABLE 73 Europe precision oncology market size, by country, 2023 - 2032 (USD Million)
• TABLE 74 Europe precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 75 Europe precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 76 Europe precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 77 Europe precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 78 Europe precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 79 Europe precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 80 Europe precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 81 Europe precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 82 Germany precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 83 Germany precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 84 Germany precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 85 Germany precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 86 Germany precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 87 Germany precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 88 Germany precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 89 Germany precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 90 UK precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 91 UK precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 92 UK precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 93 UK precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 94 UK precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 95 UK precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 96 UK precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 97 UK precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 98 France precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 99 France precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 100 France precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 101 France precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 102 France precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 103 France precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 104 France precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 105 France precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 106 Spain precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 107 Spain precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 108 Spain precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 109 Spain precision oncology market size, by diagnostics, 2023 - 2032 (USD Million
• TABLE 110 Spain precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 111 Spain precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 112 Spain precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 113 Spain precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 114 Italy precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 115 Italy precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 116 Italy precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 117 Italy precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 118 Italy precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 119 Italy precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 120 Italy precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 121 Italy precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 122 Rest of Europe precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 123 Rest of Europe precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 124 Rest of Europe precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 125 Rest of Europe precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 126 Rest of Europe precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 127 Rest of Europe precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 128 Rest of Europe precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 129 Rest of Europe precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 130 Asia Pacific precision oncology market size, by country, 2018 - 2022 (USD Million)
• TABLE 131 Asia Pacific precision oncology market size, by country, 2023 - 2032 (USD Million)
• TABLE 132 Asia Pacific precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 133 Asia Pacific precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 134 Asia Pacific precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 135 Asia Pacific precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 136 Asia Pacific precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 137 Asia Pacific precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 138 Asia Pacific precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 139 Asia Pacific precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 140 China precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 141 China precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 142 China precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 143 China precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 144 China precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 145 China precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 146 China precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 147 China precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 148 Japan precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 149 Japan precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 150 Japan precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 151 Japan precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 152 Japan precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 153 Japan precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 154 Japan precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 155 Japan precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 156 India precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 157 India precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 158 India precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 159 India precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 160 India precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 161 India precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 162 India precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 163 India precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 164 Australia precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 165 Australia precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 166 Australia precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 167 Australia precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 168 Australia precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 169 Australia precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 170 Australia precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 171 Australia precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 172 Rest of Asia Pacific precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 173 Rest of Asia Pacific precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 174 Rest of Asia Pacific precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 175 Rest of Asia Pacific precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 176 Rest of Asia Pacific precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 177 Rest of Asia Pacific precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 178 Rest of Asia Pacific precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 179 Rest of Asia Pacific precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 180 Latin America precision oncology market size, by country, 2018 - 2022 (USD Million)
• TABLE 181 Latin America precision oncology market size, by country, 2023 - 2032 (USD Million)
• TABLE 182 Latin America precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 183 Latin America precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 184 Latin America precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 185 Latin America precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 186 Latin America precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 187 Latin America precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 188 Latin America precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 189 Latin America precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 190 Brazil precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 191 Brazil precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 192 Brazil precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 193 Brazil precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 194 Brazil precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 195 Brazil precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 196 Brazil precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 197 Brazil precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 198 Mexico precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 199 Mexico precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 200 Mexico precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 201 Mexico precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 202 Mexico precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 203 Mexico precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 204 Mexico precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 205 Mexico precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 206 Rest of Latin America precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 207 Rest of Latin America precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 208 Rest of Latin America precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 209 Rest of Latin America precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 210 Rest of Latin America precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 211 Rest of Latin America precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 212 Rest of Latin America precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 213 Rest of Latin America precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 214 Middle East & Africa precision oncology market size, by country, 2018 - 2022 (USD Million)
• TABLE 215 Middle East & Africa precision oncology market size, by country, 2023 - 2032 (USD Million)
• TABLE 216 Middle East & Africa precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 217 Middle East & Africa precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 218 Middle East & Africa precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 219 Middle East & Africa precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 220 Middle East & Africa precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 221 Middle East & Africa precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 222 Middle East & Africa precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 223 Middle East & Africa precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 224 South Africa precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 225 South Africa precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 226 South Africa precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 227 South Africa precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 228 South Africa precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 229 South Africa precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 230 South Africa precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 231 South Africa precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 232 Saudi Arabia precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 233 Saudi Arabia precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 234 Saudi Arabia precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 235 Saudi Arabia precision oncology market size, by diagnostics, 2023 - 2032 (USD Million
• TABLE 236 Saudi Arabia precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 237 Saudi Arabia precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 238 Saudi Arabia precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 239 Saudi Arabia precision oncology market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 240 Rest of Middle East & Africa precision oncology market size, by product type, 2018 - 2022 (USD Million)
• TABLE 241 Rest of Middle East & Africa precision oncology market size, by product type, 2023 - 2032 (USD Million)
• TABLE 242 Rest of Middle East & Africa precision oncology market size, by diagnostics, 2023 - 2032 (USD Million)
• TABLE 243 Rest of Middle East & Africa precision oncology market size, by diagnostics, 2018 - 2022 (USD Million)
• TABLE 244 Rest of Middle East & Africa precision oncology market size, by cancer type, 2018 - 2022 (USD Million)
• TABLE 245 Rest of Middle East & Africa precision oncology market size, by cancer type, 2023 - 2032 (USD Million)
• TABLE 246 Rest of Middle East & Africa precision oncology market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 247 Rest of Middle East & Africa precision oncology market size, by end-user, 2023 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Precision oncology industry 360 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by product type
• FIG 8 Growth potential analysis, by cancer type
• FIG 9 Growth potential analysis, by end-user
• FIG 10 Porter's analysis
• FIG 11 PESTEL analysis
• FIG 12 Company matrix analysis, 2022
• FIG 13 Competitive analysis of major market players, 2022
• FIG 14 Competitive positioning matrix, 2022
• FIG 15 Strategic dashboard, 2022